1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Previous Advocacy Updates

Previous Advocacy Updates

  • March 7, 2023

    The Washington State Pathology Society, in collaboration with the CAP, and the Washington State Medical Association, delayed a switch from the states’ balance billing dispute resolution process to the federal independent dispute resolution system for at least six months.

  • February 28, 2023

    The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) voted to recommend updating its Medicare coverage with evidence development (CED) criteria to improve the timeliness of trials and the diversity of data collected. However, the CAP and others, including MEDCAC advisers, remain concerned that CED restrictions will limit patient access.

  • February 21, 2023

    The American Medical Association (AMA), the CAP, and over 110 other medical societies supported meaningful prior authorization reforms proposed for Medicare Advantage and the Medicare prescription drug benefit.

  • February 14, 2023

    Once again, a federal judge in Texas agreed with physicians that the government’s regulations for the No Surprises Act are inconsistent with the statute.

  • February 7, 2023

    The Cancer Leadership Council, of which the CAP is a member, asked the Centers for Medicare & Medicaid Services (CMS) to ensure that health plan essential benefits include molecular diagnostic tests and chimeric antigen receptor (CAR) T-cell therapies.

  • January 30, 2023

    The Centers for Medicare & Medicaid Services (CMS) announced the first award of 200 Medicare-supported graduate medical education (GME) slots. These 200 are part of the 1,000 GME slots that Congress created as part of the Consolidation Appropriations Act of 2021.

  • January 24, 2023

    As the 118th Congress took office in January, Republicans hold a slight majority in the House, making for a new speaker and committee leadership. House Speaker Kevin McCarthy (R-CA) was sworn in on January 7 along with the rest of Congress.

  • January 10, 2023

    With a new year, there are several new laws and regulations now impacting pathologists and their practices.

  • December 20, 2022

    In its 2023 federal funding legislation, Congress mitigated next year’s scheduled Medicare cuts to physicians, delayed implementation of pending cuts to clinical laboratory fees, and included a bill championed by the CAP to ensure the nation is prepared for future pandemics. The legislation did not include some other measures which the CAP asked Congress to adopt.

  • December 14, 2022

    As Congress debates its year-end legislation for 2022, the CAP has laid out its priorities for inclusion in the year-end omnibus appropriations package.

  • December 6, 2022

    As Congress negotiates year-end legislation, the CAP is urging lawmakers to prevent scheduled Medicare cuts in 2023 and protect Medicare payment for clinical laboratory fees before December 31. The CAP is also actively advocating for policies that prepare the country for future pandemics and to protect provisions in legislation providing guardrails on the federal oversight of laboratory tests.

  • November 22, 2022

    The CAP strongly opposed the health insurer Highmark’s new credentialing requirements for next-generation sequencing testing that imposes independent third-party validation of NGS results and/or variants of uncertain significance interpretation.

  • November 15, 2022

    The CAP recently asked the Centers for Medicare & Medicaid Services to evaluate remote sign-out practices for pathologists after the public health emergency ends.

  • November 8, 2022

    In an advocacy win for the pathologists, the Centers for Medicare & Medicaid Services finalized the proper rank order of the clinical labor rates for histotechnologists and laboratory technicians in the final 2023 Medicare Physician Fee Schedule (PFS).

  • November 1, 2022

    Special Issue: On November 1, the Centers for Medicare & Medicaid Services released the 2023 Medicare payment regulations, including the final 2023 Medicare Fee Schedule and Quality Payment Program regulations.

  • November 1, 2022

    In response to a congressional request for information regarding the potential reform of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), the CAP provided feedback regarding pathologists’ experience in dealing with the current payment program and potential actions Congress could take to stabilize the Medicare payment system by reforming MACRA.

  • October 25, 2022

    In response to an outbreak of Ebola in East Africa, the US Centers for Disease Control and Prevention (CDC) released guidance for clinical laboratories for Ebola specimen collection in the United States on October 18.

  • October 18, 2022

    On September 28, CAP President-elect Donald Karcher, MD, FCAP, urged in public testimony to the Council of the DC to reconsider laboratory personnel licensure and additional statutory fixes in lieu of repeal within the personnel clean-up bill.

  • October 11, 2022

    During the CAP 22 Annual Meeting, CAP members gathered in person and virtually and participate in an informative Advocacy Town Hall.

  • October 4, 2022

    The Council of Medical Specialty Societies (CMSS), a coalition of 48 specialty societies, awarded the CAP $100,000 grant to study how to make pathology reports more patient-centered and understandable.

Analysis of Final 2020 Medicare Rule

Read the special report Right Arrow

Direct questions or comments to:

advocacyupdate@cap.org

202-354-7100

  1. Left Arrow
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. Right Arrow
Viewing 101-120 of 459